Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

HOXDeRNA activates a cancerous transcription program and super enhancers via genome-wide binding

Molecular Cell(2024)10.1016/j.molcel.2024.09.018Source: DataRank Database

HOXDeRNA activates a cancerous transcription program and super enhancers via genome-wide binding is a research paper published in Molecular Cell (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.17)OA: greenTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Prakash Kharel ORCID,Yanhong Zhang ORCID,Anton Karelin,Abdellatif El Khayari ORCID,Pavel Ivanov ORCID

Live enrichment

PubMed:39383879 PMC:PMC11490371 OpenAlex:https://openalex.org/W4403223116

NCI NIH HHS

Grant: R01 CA215072

NINDS NIH HHS

Grant: R01 NS113929

NIGMS NIH HHS

Grant: R01 GM126150

NIGMS NIH HHS

Grant: R01 GM146997

NINDS NIH HHS

Grant: R21 NS098051

NIA NIH HHS

Grant: R21 AG060019

NIH

FWCI

3.17

Citation Percentile

0.9%

Citation Trend

2023

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11490371/pdf/nihms-2025344.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1097276524007755?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1097276524007755?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11490371

Fields of Study

Cancer-related molecular mechanisms researchRNA modifications and cancerGenomics and Chromatin DynamicsHumansRNA, Long NoncodingEnhancer Elements, GeneticGliomaGene Expression Regulation, NeoplasticAstrocytesTranscription FactorsPromoter Regions, GeneticCpG IslandsCell Transformation, NeoplasticCell Line, TumorTranscription, GeneticBinding SitesSuper Enhancers

MeSH Terms

Super EnhancersAstrocytesBinding SitesCell Transformation, NeoplasticEnhancer Elements, GeneticGliomaHumansPromoter Regions, GeneticTranscription FactorsTranscription, GeneticGene Expression Regulation, NeoplasticCpG IslandsCell Line, TumorRNA, Long Noncoding

Keywords

BiologyEnhancerComputational biologyTranscription factorGenomeTranscription (linguistics)DNA-binding proteinGeneticsCell biologyGeneCpGTranscription factorsGliomaAstrocytesStem CellsLong Non-coding RnaPrc2Enhancer RnaSuper EnhancersRg4

HOXDeRNA activates a cancerous transcription program and super enhancers via genome-wide binding

FAIR Checklist

Authors (7)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)